🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
299,00 USD
Máx. histórico
322,75
6 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-7,36%
Rango 52 semanas
175,89 – 326,63
Variación hoy
-5,42%
Cierre anterior
316,13
Rango de hoy
297,63 – 318,98
Volumen hoy
247.610
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 120,08 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 21 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 08/10/1999 | 29,01 | 29,01 | 28,07 | 28,54 | -1,61% | 3,23% | 41.357 |
| 07/10/1999 | 28,89 | 29,13 | 28,07 | 29,01 | +1,22% | 3,64% | 30.190 |
| 06/10/1999 | 28,31 | 29,48 | 28,07 | 28,66 | +1,24% | 4,96% | 30.965 |
| 05/10/1999 | 28,31 | 29,01 | 28,07 | 28,31 | +0,83% | 3,31% | 24.820 |
| 04/10/1999 | 29,36 | 29,36 | 28,07 | 28,07 | -4,76% | 4,38% | 33.583 |
| 01/10/1999 | 29,01 | 29,48 | 28,07 | 29,48 | +3,28% | 4,84% | 27.064 |
| 30/09/1999 | 29,36 | 29,59 | 28,07 | 28,54 | -3,17% | 5,18% | 78.200 |
| 29/09/1999 | 29,71 | 29,94 | 28,89 | 29,48 | +1,61% | 3,54% | 50.788 |
| 28/09/1999 | 29,83 | 30,18 | 28,77 | 29,01 | -1,59% | 4,71% | 84.131 |
| 27/09/1999 | 30,41 | 30,76 | 29,48 | 29,48 | +1,61% | 4,23% | 40.663 |
| 24/09/1999 | 29,94 | 30,88 | 29,01 | 29,01 | -3,13% | 6,25% | 76.196 |
| 23/09/1999 | 30,41 | 32,75 | 29,94 | 29,94 | +1,59% | 9,23% | 73.791 |
| 22/09/1999 | 29,01 | 31,35 | 29,01 | 29,48 | +2,44% | 8,06% | 50.174 |
| 21/09/1999 | 30,65 | 30,88 | 28,54 | 28,77 | -0,81% | 7,63% | 82.421 |
| 20/09/1999 | 30,41 | 31,35 | 28,54 | 29,01 | -6,06% | 9,23% | 53.059 |
| 17/09/1999 | 30,18 | 30,88 | 29,01 | 30,88 | +4,76% | 6,20% | 50.307 |
| 16/09/1999 | 30,65 | 30,65 | 27,84 | 29,48 | -2,33% | 9,16% | 79.749 |
| 15/09/1999 | 30,88 | 32,05 | 29,94 | 30,18 | -0,77% | 6,82% | 52.792 |
| 14/09/1999 | 31,70 | 32,75 | 30,41 | 30,41 | -3,70% | 7,38% | 64.307 |
| 13/09/1999 | 34,39 | 34,62 | 31,35 | 31,58 | -8,16% | 9,52% | 83.543 |
| 10/09/1999 | 35,79 | 36,49 | 33,69 | 34,39 | -3,29% | 7,84% | 74.593 |
| 09/09/1999 | 35,79 | 36,49 | 34,62 | 35,56 | +2,70% | 5,23% | 169.998 |
| 08/09/1999 | 31,82 | 36,14 | 31,35 | 34,62 | +10,45% | 15,07% | 200.509 |
| 07/09/1999 | 29,94 | 31,82 | 29,94 | 31,35 | +8,06% | 6,25% | 160.808 |
| 03/09/1999 | 29,24 | 29,48 | 27,60 | 29,01 | +5,98% | 6,40% | 186.322 |
| 02/09/1999 | 27,96 | 29,24 | 26,90 | 27,37 | +11,43% | 8,37% | 597.892 |
| 01/09/1999 | 25,27 | 25,50 | 24,10 | 24,56 | -2,78% | 5,56% | 148.598 |
| 31/08/1999 | 25,03 | 25,27 | 24,33 | 25,27 | +0,93% | 3,74% | 61.502 |
| 30/08/1999 | 25,50 | 25,50 | 24,56 | 25,03 | -1,38% | 3,67% | 81.780 |
| 27/08/1999 | 25,97 | 26,32 | 24,80 | 25,38 | -2,25% | 5,86% | 125.782 |